Ministry of Health approves booster dose for health professionals

Rate our content: Aguarde enquanto o login é efetuado

There was an error making your request , please try again!

Your evaluation is essential for us to continue improving the Pebmed Portal

Do you want to access this and other content in full?

Register for Free

Already registered? Make your login

Login or register for free to have unlimited access to all articles, clinical cases and tools on the PEBMED Portal

The PEBMED Portal is intended for doctors and health professionals. Our contents inform recent panoramas of medicine.

If you are interested in publishing your curriculum on the internet, connecting with patients and increasing your differentials, create a free profile on AgendarConsulta, the partner site of PEBMED.

Last Friday, the 24th, the Ministry of Health announced the application of the booster dose against Covid-19 for healthcare professionals. The measure was approved at a meeting at the Technical Chamber of Advice on Immunization (CTAI – Covid).

The dose of booster should preferably be given with the Pfizer vaccine, regardless of which vaccine was taken in the regular vaccination. The additional dose should be given at least six months after the healthcare provider has completed the vaccination with the second dose. This initiative aims to ensure increased immunity for those on the front lines of the fight against Covid-19.

Know more : Transplant patients and third dose of the Covid-19 vaccine

dose de reforço

Make the best clinical decisions, update yourself. Sign up and access medical content written and peer-reviewed for free

Boosting dose for the population

According to data released by the Ministry of Health, 412.5 thousand Brazilians have already received the booster dose so far, and they are elderly over 70 years old and immunosuppressed.

Studies about the additional dose

With the emergence of the Delta variant and the increase in the number of cases in Brazil and other countries, concern arose regarding the effectiveness of existing vaccines. At the same time, the durability of the protection provided by the vaccine and whether the vaccine response is the same in all populations are questions that have not yet been fully elucidated.

In Brazil, Anvisa has already authorized the realization of two studies that will evaluate a complementary dose to the current regimens. At the same time, the FDA approved the use of a third dose in immunosuppressed people.

Read too: After all, how many doses of the anti-Covid-19 vaccine will be needed?

The CEO of Pfizer, Albert Bourla, announced that, given the data collected by industry, an additional dose of the immunizer would likely be needed 6 to 12 months after immunization with two doses and that booster doses would likely be needed annually. These comments are in line with what the CEO of Johnson & Johnson (group to which Janssen belongs), Alex Gorsky said, who also believes that vaccination against Covid-19 should be annual.

*This article was reviewed by the PEBMED medical team

Bibliographic reference:

See more benefits of being a user of the PEBMED Portal: See more benefits of being a user
from the PEBMED Portal:

7 days free with the Whitebook Application made for you, doctor, designed to bring security and objectivity to your clinical decision.

Free access to the Nursebook Access essential information for your daily life such as anamnesis, semiology.

Free access to the Forum Space for exchanging experiences and constructive comments about it of topics related to Medicine and Health.

Unlimited access Get access to news, studies, updates and more content written and reviewed by experts

Test your knowledge Answer our quizzes and study in a simple and fun way

Personalized content Receive studies, updates, new behaviors and other content segmented by specialties by email

The PEBMED Portal is intended for for doctors and health professionals. Our contents inform recent panoramas of medicine.

If you are interested in publishing your curriculum on the internet, connecting with patients and increasing your differentials, create a free profile on AgendarConsulta, the partner site of PEBMED.

Note: This article has been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at the original source Click Here

Related Posts
Does maternal infection in the corona lead to placental injury and miscarriage? thumbnail

Does maternal infection in the corona lead to placental injury and miscarriage?

הפתולוגיה של השליה בהריונות בהם התרחשה הדבקה בנגיף הקורונה (SARS-CoV-2) נראית לכאורה כלא ספציפית. עם זאת, זיהוי של נגעים בשליה הנגרמים עקב זיהום בקורונה יהווה התקדמות משמעותית, שתאפשר לשפר את ניהול ההריונות ולזהות את המנגנונים הכרוכים בהעברה אנכית אפשרית. במחקר שפורסם בכתב העת Modern Pathology בחנו החוקרים את הממצאים הפתולוגיים בשליות של 198 נשים בהריון…
Read More
How to differentiate inflammatory demyelinating diseases in children by imaging tests? thumbnail

How to differentiate inflammatory demyelinating diseases in children by imaging tests?

Avalie o nosso conteúdo: Houve um erro fazendo sua requisição, por favor tente novamente! Obrigado!Sua avaliação é fundamental para que a gente continue melhorando o Portal Pebmed Quer acessar esse e outros conteúdos na íntegra? Cadastrar GrátisJá tem cadastro? Faça seu login Faça seu login ou cadastre-se gratuitamente para ter acesso ilimitado a todos os…
Read More
Index Of News
Total
0
Share